Literature DB >> 17191094

Particle size analysis in pharmaceutics: principles, methods and applications.

Boris Y Shekunov1, Pratibhash Chattopadhyay, Henry H Y Tong, Albert H L Chow.   

Abstract

Physicochemical and biopharmaceutical properties of drug substances and dosage forms can be highly affected by the particle size, a critical process parameter in pharmaceutical production. The fundamental issue with particle size analysis is the variety of equivalent particle diameters generated by different methods, which is largely ascribable to the particle shape and particle dispersion mechanism involved. Thus, to enable selection of the most appropriate or optimal sizing technique, cross-correlation between different techniques may be required. This review offers an in-depth discussion on particle size analysis pertaining to specific pharmaceutical applications and regulatory aspects, fundamental principles and terminology, instrumentation types, data presentation and interpretation, in-line and process analytical technology. For illustration purposes, special consideration is given to the analysis of aerosols using time-of-flight and cascade impactor measurements, which is supported by a computational analysis conducted for this review.

Mesh:

Substances:

Year:  2006        PMID: 17191094     DOI: 10.1007/s11095-006-9146-7

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  57 in total

1.  Comparison of particle sizing techniques in the case of inhalation dry powders.

Authors:  C Bosquillon; C Lombry; V Preat; R Vanbever
Journal:  J Pharm Sci       Date:  2001-12       Impact factor: 3.534

2.  Polydisperse powder mixtures: effect of particle size and shape on mixture stability.

Authors:  Vidya Swaminathan; Dane O Kildsig
Journal:  Drug Dev Ind Pharm       Date:  2002-01       Impact factor: 3.225

Review 3.  Pulmonary drug delivery systems: recent developments and prospects.

Authors:  H M Courrier; N Butz; Th F Vandamme
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2002       Impact factor: 4.889

4.  Characterization of an active pharmaceutical ingredient by its dissolution properties: amoxicillin trihydrate as a model drug.

Authors:  Stefan Horkovics-Kovats
Journal:  Chemotherapy       Date:  2004-11-03       Impact factor: 2.544

Review 5.  Toxic potential of materials at the nanolevel.

Authors:  Andre Nel; Tian Xia; Lutz Mädler; Ning Li
Journal:  Science       Date:  2006-02-03       Impact factor: 47.728

Review 6.  Recent advances in pulmonary drug delivery using large, porous inhaled particles.

Authors:  D A Edwards; A Ben-Jebria; R Langer
Journal:  J Appl Physiol (1985)       Date:  1998-08

7.  Liposomal amikacin dry powder inhaler: effect of fines on in vitro performance.

Authors:  Shrenik P Shah; Ambikanandan Misra
Journal:  AAPS PharmSciTech       Date:  2004-08-09       Impact factor: 3.246

8.  Nasal delivery of human growth hormone: in vitro and in vivo evaluation of a thiomer/glutathione microparticulate delivery system.

Authors:  Verena M Leitner; Davide Guggi; Alexander H Krauland; Andreas Bernkop-Schnürch
Journal:  J Control Release       Date:  2004-11-05       Impact factor: 9.776

9.  Tableting of Eudragit RS and propranolol hydrochloride solid dispersion: effect of particle size, compaction force, and plasticizer addition on drug release.

Authors:  F Sadeghi; H Afrasiabi Garekani; F Goli
Journal:  Drug Dev Ind Pharm       Date:  2004-08       Impact factor: 3.225

10.  Formulation of a dry powder influenza vaccine for nasal delivery.

Authors:  Robert J Garmise; Kevin Mar; Timothy M Crowder; C Robin Hwang; Matthew Ferriter; Juan Huang; John A Mikszta; Vincent J Sullivan; Anthony J Hickey
Journal:  AAPS PharmSciTech       Date:  2006-03-10       Impact factor: 3.246

View more
  60 in total

Review 1.  Best practices in cancer nanotechnology: perspective from NCI nanotechnology alliance.

Authors:  William C Zamboni; Vladimir Torchilin; Anil K Patri; Jeff Hrkach; Stephen Stern; Robert Lee; Andre Nel; Nicholas J Panaro; Piotr Grodzinski
Journal:  Clin Cancer Res       Date:  2012-06-05       Impact factor: 12.531

2.  Characterization of a nanoparticulate drug delivery system using scanning ion occlusion sensing.

Authors:  Lin Yang; Murray F Broom; Ian G Tucker
Journal:  Pharm Res       Date:  2012-05-26       Impact factor: 4.200

3.  Shape-tunable wax microparticle synthesis via microfluidics and droplet impact.

Authors:  Doojin Lee; Shilpa N Beesabathuni; Amy Q Shen
Journal:  Biomicrofluidics       Date:  2015-12-15       Impact factor: 2.800

4.  Multimodal Dispersion of Nanoparticles: A Comprehensive Evaluation of Size Distribution with 9 Size Measurement Methods.

Authors:  Fanny Varenne; Ali Makky; Mireille Gaucher-Delmas; Frédéric Violleau; Christine Vauthier
Journal:  Pharm Res       Date:  2016-02-10       Impact factor: 4.200

Review 5.  Particle engineering for pulmonary drug delivery.

Authors:  Albert H L Chow; Henry H Y Tong; Pratibhash Chattopadhyay; Boris Y Shekunov
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

Review 6.  Pharmaceutical particle engineering via spray drying.

Authors:  Reinhard Vehring
Journal:  Pharm Res       Date:  2007-11-28       Impact factor: 4.200

7.  Design of experiments-based monitoring of critical quality attributes for the spray-drying process of insulin by NIR spectroscopy.

Authors:  Morten Jonas Maltesen; Marco van de Weert; Holger Grohganz
Journal:  AAPS PharmSciTech       Date:  2012-05-15       Impact factor: 3.246

8.  Understanding the Impacts of Surface Compositions on the In-Vitro Dissolution and Aerosolization of Co-Spray-Dried Composite Powder Formulations for Inhalation.

Authors:  Sharad Mangal; Rongkun Xu; Heejun Park; Dmitry Zemlyanov; Nivedita Shetty; Yu-Wei Lin; David Morton; Hak-Kim Chan; Jian Li; Qi Tony Zhou
Journal:  Pharm Res       Date:  2018-11-07       Impact factor: 4.200

Review 9.  FDA critical path initiatives: opportunities for generic drug development.

Authors:  Robert A Lionberger
Journal:  AAPS J       Date:  2008-02-20       Impact factor: 4.009

10.  Development of sustained-release microspheres for the delivery of SAR 1118, an LFA-1 antagonist intended for the treatment of vascular complications of the eye.

Authors:  Sarath Yandrapu; Uday B Kompella
Journal:  J Ocul Pharmacol Ther       Date:  2012-12-20       Impact factor: 2.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.